Lada Nuzhna’s Post

Check out our latest essay for Issue 04 of Asimov Press. It's about artificial wombs, who's working on them, and roadblocks in bringing them to clinical trials.

Explore our latest Life Science Update (September 2024) and gain insights into recent legal developments that will have a bearing on the life science industry across Europe, with a particular focus on Denmark.

The Miracle of Life: A Prenatal Journey From a microscopic cluster of cells to the incredible formation of a new human being—prenatal development is a story of awe-inspiring transformation! Discover the science behind this extraordinary journey, from the germinal stage to the embryonic and fetal milestones that shape who we become. 🧬 Ready to explore the magic of life before birth? Dive into our latest blog post and uncover the wonders of human development: Read here: https://lnkd.in/dWEH9ae5 . . . . #LifeBeforeBirth #PrenatalDevelopment #ScientificJourney #Manuscriptedit #ResearchMatters #ScholarlyInsights

April 4, at 13:00h, Yil Severijns will defend her PhD thesis titled "𝗠𝘆, 𝘆𝗼𝘂𝗿 𝗼𝗿 𝗼𝘂𝗿 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻? 𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴, 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗶𝗻𝗴 𝘁𝗵𝗲 𝗱e𝗰𝗶𝘀𝗶𝗼𝗻-𝗺𝗮𝗸𝗶𝗻𝗴 𝗽𝗿𝗼𝗰𝗲𝘀𝘀 𝗳𝗼𝗿 𝗰𝗼𝘂𝗽𝗹𝗲𝘀 𝗮𝘁 𝗿𝗶𝘀𝗸 𝗼𝗳 𝘁𝗿𝗮𝗻𝘀𝗺𝗶𝘁𝘁𝗶𝗻𝗴 𝗮 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗼 𝘁𝗵𝗲𝗶𝗿 𝗼𝗳𝗳𝘀𝗽𝗿𝗶𝗻𝗴" at Universiteit Maastricht. 💻 Watch the video of the PhD defence ceremony here: https://lnkd.in/ejU5GFtv 📘 Read more about the thesis here: https://lnkd.in/eaQKsNeJ **𝗦𝗨𝗠𝗠𝗔𝗥𝗬** Couples at risk of transmitting a disease to their offspring, face challenges when deciding if, and how, to fulfil their desire to have children. Factors such as the severity of the condition and the risk of inheritance play a role in this decision-making process. This research aimed to gain insight into the reproductive decision-making process, particularly how partners make decisions together, and to develop and test a decision aid tailored to the needs of couples. Results indicate that couples generally make decisions together, with women often having more influence due to their potential role in carrying a pregnancy. The decision aid received positive feedback and resulted in increased knowledge, realistic expectations, and deliberation. Additionally, it helped individuals feel better prepared to make a decision. 𝗣𝗿𝗼𝗺𝗼𝘁𝗼𝗿𝗲𝘀: Prof. dr. Christine De Die, Prof. dr. Hein De Vries 𝗖𝗼-𝗽𝗿𝗼𝗺𝗼𝘁𝗼𝗿: Dr. Liesbeth van Osch Care And Public Health Research Institute (CAPHRI) GROW - Research Institute for Oncology and Reproduction #Genetics #ReproductiveOptions #DecisionAid #DecidingTogether

Dear all, I am happy to share a preprint of our new paper: “Polygenic susceptibility for multiple sclerosis is associated with working memory in low-performing young adults” https://lnkd.in/dZduMqwu

If you are interested in #ifv #infertility #innovation #genetics #embryology #autism #squizophrenia #wholegenome sequencing #matabolomics #ai and ways to improve outcomes of implantation and #pregnancy rates, this video is for you. Santiago Munne and Nabil Arrach, Ph.D, MBA explains the innovative research at Progenesis

With the population’s chances of good healthcare and their needs varying, how do we place a greater focus on equity in improvement research?     We welcome the new fellowship cohort whose projects address different aspects of equity and improvement. From how well NHS staff with chronic illnesses and disability are supported, understanding Black women’s experiences of prenatal genetic testing, to studying how people in deprived areas receive prevention advice.     Learn about the range of perspectives and research expertise our new fellows bring and how they are tackling important uncertainties in what works to reduce inequities in healthcare.    Learn about our fellows’ research in our new story: https://ths.im/4aoZ5QV

We can find treatments and cures for childhood dementia.  After our recent analysis of global childhood dementia research revealed concerning neglect and inequity, we brought experts together to talk about the many opportunities for progress. Here are some snippets from this webinar on this important topic. You can watch the full webinar and view our report on research here: https://lnkd.in/gfkRP8MV Featured here are: Matthew Ellinwood, Chief Scientific Officer at the National MPS Society and Professor Emeritus of Animal Science, Iowa State University. Dr Leslie Meltzer, Chief Medical Officer, Orchard Therapeutics. Felicity McManus, Family Advocate and parent of a child with a dementia condition. Professor John Christodoulou, Chair of Genomic Medicine, Department of Paediatrics, University of Melbourne and the Co-Leader of the Brain and Mitochondrial Research Group at the Murdoch Children's Research Institute. Dr Kristina Elvidge, Head of Research, Childhood Dementia Initiative. #clinicaltrials #research #innovation #progress

**new lab preprint** We have spent a lot of time exploring PFC alterations following adolescent binge drinking in mice. But when it came to adolescent EtOH effects on adulthood EtOH… we just never saw it. Work by Avery Sicher and funded by The National Institutes of Health and Huck Institutes of the Life Sciences. & it turns out we weren’t the only ones with this phenotype. We teamed up with Binghamton University and Scripps Research and across 3 labs, multiple drinking models, rats and mice… no meaningful Adolescent x Adulthood EtOH interactions. (this doesn’t mean there aren’t really critical ramifications of Adolescent EtOH – e.g. see Avery's ephys paper - https://lnkd.in/eTmGFKdJ but, consistently, increased adulthood EtOH isn’t one in our hands). To us, this is really important for how we think about the animal literature + human literature & social factors that are sometimes outside the scope of these preclinical models - but some of which can be integrated. https://lnkd.in/d2sEy3Z7

𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝗼𝘂𝗻𝘁𝗮𝗶𝗻 𝗼𝗳 𝗬𝗼𝘂𝘁𝗵? 𝗥𝗮𝗽𝗮𝗺𝘆𝗰𝗶𝗻’𝘀 𝗥𝗼𝗹𝗲 𝗶𝗻 𝗔𝗴𝗶𝗻𝗴 𝗮𝗻𝗱 𝗙𝗲𝗿𝘁𝗶𝗹𝗶𝘁𝘆... 1️⃣ Longevity Potential: Rapamycin, often used in organ transplants, is showing promise for extending female fertility and potentially even lifespan. 2️⃣ Menopause Delay: Studies hint that rapamycin might delay menopause by several years, which could have huge health and social impacts. 3️⃣ Broader Health Boost: This drug might also improve overall health, giving cells a new "lease on life." Catch the full manuscript for an in-depth look: https://lnkd.in/eshnEWid #Longevity #HealthcareInnovation #Fertility #AgingResearch #LifeScience #antiaging #aging #rapamycin